✦ LIBER ✦

A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC

✍ Scribed by Mattson, K.; Tamminen, K.; Nikkanen, V.; Viren, M.; Isokangas, O.-P.; Le Bras, F.; Barbet, I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of cisplatin (CDDP), Ifos

✍ Baldini, E.; Tibaldi, C.; Ardizzoni, A.; Chella, A.; Angeletti, C.A.; Silvano, G 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Phase II study of cisplatin (CDDP), ifos

✍ Baldini, E.; Tibaldi, C.; Chella, A.; Angeletti, C.A.; Silvano, G.; Conte, P.F. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 196 KB

A multicenter phase II trial with gemcit

✍ E. Laack; T. Mende; J.G. Saal; A. Chemaissani; J. Scholtze; C. Lorenz; K. Dalhof 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Phase III study of gemcitabine (GEM) plu

✍ Lorusso, V; Mancarella, S; Carpagnano, F; Di Rienzo, G; Oisternino, L; Napoli, G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Multicentric randomized phase II study w

✍ Ricci, S; Antonuzzo, A; Galli, L; Algeri, R; Bonifazi, V; Andrei, A; Petruzzelli 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Phase II randomised trial: Gemcitabine (

✍ Santomaggio, C; Portalone, L; De Marinis, F; Coppolino, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB